Clinical Trial Update: Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia [NA]

View source ↗

Summary

This clinical trial update notes the completion of a cell therapy study targeting CD7-positive acute myeloid leukemia or mixed lineage leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Mixed Lineage Leukemia

Drugs mentioned

• CD7-targeted cell therapy (CD7-targeted cell therapy)

Snippet

Sponsor: Hebei Senlang Biotechnology Inc., Ltd. | Conditions: Leukemia, T Cell | NA | Status: COMPLETED